HMG-CoA Reductase Inhibitor [EPC]

291284 reported adverse events

Drugs of this class: SIMVASTATIN LOVASTATIN EZETIMIBE AND SIMVASTATIN ATORVASTATIN CALCIUM PITAVASTATIN MAGNESIUM ROSUVASTATIN

These side effects are most commonly reported by patients taking drugs of the HMG-CoA Reductase Inhibitor [EPC] class:

#	Side effect	Count
0	FATIGUE	15049
1	NAUSEA	14607
2	DRUG INEFFECTIVE	14288
3	DYSPNOEA	13909
4	DIARRHOEA	12717
5	DIZZINESS	12410
6	ASTHENIA	10563
7	PAIN	10206
8	MYALGIA	10096
9	FALL	9977

See all common reactions for HMG-CoA Reductase Inhibitor [EPC]

Drugs of the HMG-CoA Reductase Inhibitor [EPC] class are most commonly taken among patients reporting these side effects:

#	Side effect	Count	Frequency
0	IMMUNE-MEDIATED NECROTISING MYOPATHY	257	0.4565
1	MYOPATHY	1494	0.2580
2	RHABDOMYOLYSIS	6471	0.2273
3	HYPERPARATHYROIDISM SECONDARY	390	0.2270
4	NEPHROGENIC ANAEMIA	703	0.2189
5	REBOUND ACID HYPERSECRETION	431	0.1665
6	MYOSITIS	821	0.1565
7	POLYMYOSITIS	191	0.1549
8	SELF ESTEEM DECREASED	186	0.1523
9	BLOOD CREATINE PHOSPHOKINASE INCREASED	2967	0.1338

See all enriched reactions for HMG-CoA Reductase Inhibitor [EPC]